BioCentury
ARTICLE | Clinical News

Novavax Inc preclinical data

April 13, 2015 7:00 AM UTC

In non-human primates, 2 injections of 5 ug EBOV GP vaccine plus the company’s Matrix M adjuvant protected animals from a lethal challenge with Ebola virus for 18 days post-challenge whereas the chal...